HEADER HYDROLASE/HYDROLASE INHIBITOR 12-SEP-07 2R9B TITLE STRUCTURAL ANALYSIS OF PLASMEPSIN 2 FROM PLASMODIUM FALCIPARUM TITLE 2 COMPLEXED WITH A PEPTIDE-BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN-2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 5 EC: 3.4.23.39; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDE-BASED INHIBITOR; COMPND 9 CHAIN: C, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: 3D7; SOURCE 5 GENE: PLASMEPSIN 2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: PEPTIDE-BASED INHIBITOR KEYWDS BETA FOLD ASPARTYL PROTEASE, GLYCOPROTEIN, VACUOLE, ZYMOGEN, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.LIU,M.R.MARZAHN,A.H.ROBBINS,R.MCKENNA,B.M.DUNN REVDAT 8 15-NOV-23 2R9B 1 REMARK REVDAT 7 30-AUG-23 2R9B 1 DBREF LINK REVDAT 6 25-OCT-17 2R9B 1 REMARK REVDAT 5 17-AUG-11 2R9B 1 HETNAM REVDAT 4 13-JUL-11 2R9B 1 VERSN REVDAT 3 18-AUG-10 2R9B 1 JRNL REVDAT 2 24-FEB-09 2R9B 1 VERSN REVDAT 1 27-NOV-07 2R9B 0 JRNL AUTH P.LIU,M.R.MARZAHN,A.H.ROBBINS,H.GUTIERREZ-DE-TERAN, JRNL AUTH 2 D.RODRIGUEZ,S.H.MCCLUNG,S.M.STEVENS,C.A.YOWELL,J.B.DAME, JRNL AUTH 3 R.MCKENNA,B.M.DUNN JRNL TITL RECOMBINANT PLASMEPSIN 1 FROM THE HUMAN MALARIA PARASITE JRNL TITL 2 PLASMODIUM FALCIPARUM: ENZYMATIC CHARACTERIZATION, ACTIVE JRNL TITL 3 SITE INHIBITOR DESIGN, AND STRUCTURAL ANALYSIS. JRNL REF BIOCHEMISTRY V. 48 4086 2009 JRNL REFN ISSN 0006-2960 JRNL PMID 19271776 JRNL DOI 10.1021/BI802059R REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 16040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1782 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5352 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 47 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.31200 REMARK 3 B22 (A**2) : -2.35100 REMARK 3 B33 (A**2) : -0.96100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.40700 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.370 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 17.09 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_DLU.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2R9B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044586. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JAN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18700 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.30300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1XDH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE TRIHYDRATE, 8% REMARK 280 PEG 4000, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K. 0.1 M SODIUM ACETATE TRIHYDRATE, 0.2 M AMMONIUM SULFATE, REMARK 280 PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K. 0.1 M REMARK 280 SODIUM ACETATE TRIHYDRATE, 0.2 M AMMONIUM SULFATE, PH 4.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 109.74450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.51600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 109.74450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.51600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1650 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1640 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 342 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 336 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE KPFS-(CH2-NH)-LQF PEPTIDOMIMETIC INHIBITOR OF PFPM1 IS PEPTIDE- REMARK 400 LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: KPFS-(CH2-NH)-LQF PEPTIDOMIMETIC INHIBITOR OF PFPM1 REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP B 24 OD2 ASP B 24 2558 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 240 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 11 -109.58 -87.73 REMARK 500 MET A 15 127.21 -174.40 REMARK 500 ASP A 69 -68.97 -120.11 REMARK 500 SER A 135 76.42 31.33 REMARK 500 GLN A 146 10.89 -67.85 REMARK 500 LYS A 163 -72.95 -134.23 REMARK 500 HIS A 189 147.26 -170.47 REMARK 500 LEU A 191 -66.72 -126.62 REMARK 500 ASN A 233 30.43 -153.74 REMARK 500 PRO A 240 -53.13 -13.04 REMARK 500 ASN A 251 109.79 -45.61 REMARK 500 GLU A 271 -11.81 -49.03 REMARK 500 ILE A 277 53.26 -145.49 REMARK 500 LEU A 292 116.27 -164.75 REMARK 500 PHE C 903 96.55 -53.22 REMARK 500 PHE B 11 -110.60 -88.38 REMARK 500 MET B 15 125.25 -174.74 REMARK 500 ASP B 69 -71.14 -121.24 REMARK 500 SER B 135 76.62 31.47 REMARK 500 GLN B 146 11.01 -67.92 REMARK 500 LYS B 163 -72.80 -136.38 REMARK 500 HIS B 189 147.81 -170.04 REMARK 500 LEU B 191 -66.22 -127.46 REMARK 500 GLN B 232 -57.52 -11.82 REMARK 500 ASN B 233 24.10 -171.57 REMARK 500 ASP B 235 119.10 -168.45 REMARK 500 GLU B 271 -12.06 -49.71 REMARK 500 ILE B 277 53.57 -145.70 REMARK 500 LEU B 292 114.85 -164.68 REMARK 500 PHE D 903 95.89 -52.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF PEPTIDE-BASED REMARK 800 INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF PEPTIDE-BASED REMARK 800 INHIBITOR DBREF 2R9B A 1 329 UNP P46925 PLM2_PLAFA 125 453 DBREF 2R9B C 901 908 PDB 2R9B 2R9B 901 908 DBREF 2R9B B 1 329 UNP P46925 PLM2_PLAFA 125 453 DBREF 2R9B D 901 908 PDB 2R9B 2R9B 901 908 SEQRES 1 A 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 A 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 A 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 A 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 A 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 A 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 A 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 A 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 A 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 A 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 A 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 A 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 A 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 A 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 A 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 A 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 A 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 A 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 A 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 A 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 A 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 A 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 A 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 A 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 A 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 A 329 LYS LYS ASN LEU SEQRES 1 C 8 LYS PRO PHE SER DCL LEU GLN PHE SEQRES 1 B 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 B 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 B 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 B 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 B 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 B 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 B 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 B 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 B 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 B 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 B 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 B 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 B 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 B 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 B 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 B 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 B 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 B 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 B 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 B 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 B 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 B 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 B 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 B 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 B 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 B 329 LYS LYS ASN LEU SEQRES 1 D 8 LYS PRO PHE SER DCL LEU GLN PHE HET DCL C 905 7 HET DCL D 905 7 HETNAM DCL 2-AMINO-4-METHYL-PENTAN-1-OL HETSYN DCL LEUCINOL FORMUL 2 DCL 2(C6 H15 N O) FORMUL 5 HOH *47(H2 O) HELIX 1 1 THR A 49 LYS A 55 5 7 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 PRO A 113 SER A 118 1 6 HELIX 5 5 TRP A 128 SER A 132 5 5 HELIX 6 6 PRO A 138 GLN A 146 1 9 HELIX 7 7 GLU A 174 ARG A 176 5 3 HELIX 8 8 PRO A 223 LEU A 231 1 9 HELIX 9 9 GLU A 269 TYR A 272 5 4 HELIX 10 10 GLY A 302 ARG A 307 1 6 HELIX 11 11 THR B 49 LYS B 55 5 7 HELIX 12 12 ASP B 59 SER B 63 5 5 HELIX 13 13 THR B 108 GLU B 112 5 5 HELIX 14 14 PRO B 113 SER B 118 1 6 HELIX 15 15 TRP B 128 SER B 132 5 5 HELIX 16 16 PRO B 138 GLN B 146 1 9 HELIX 17 17 GLU B 174 ARG B 176 5 3 HELIX 18 18 PRO B 223 GLN B 232 1 10 HELIX 19 19 GLU B 269 TYR B 272 5 4 HELIX 20 20 GLY B 302 ARG B 307 1 6 SHEET 1 A 6 ASP A 4 LEU A 8 0 SHEET 2 A 6 GLY A 166 ILE A 170 -1 O ILE A 170 N ASP A 4 SHEET 3 A 6 LEU A 153 TYR A 157 -1 N THR A 155 O THR A 169 SHEET 4 A 6 TYR A 309 ASP A 314 -1 O PHE A 313 N PHE A 154 SHEET 5 A 6 SER A 319 ALA A 325 -1 O GLY A 321 N VAL A 312 SHEET 6 A 6 TYR A 178 LYS A 186 -1 N GLU A 185 O VAL A 320 SHEET 1 B 8 GLU A 67 ASN A 76 0 SHEET 2 B 8 THR A 81 VAL A 93 -1 O VAL A 82 N MET A 75 SHEET 3 B 8 LEU A 96 ASP A 107 -1 O GLU A 104 N PHE A 85 SHEET 4 B 8 LEU A 40 PRO A 43 1 N VAL A 42 O VAL A 105 SHEET 5 B 8 GLY A 122 GLY A 125 -1 O ILE A 123 N TRP A 41 SHEET 6 B 8 GLN A 27 ASP A 34 1 N ILE A 32 O LEU A 124 SHEET 7 B 8 GLY A 18 VAL A 22 -1 N GLY A 18 O PHE A 31 SHEET 8 B 8 THR A 81 VAL A 93 -1 O THR A 92 N GLU A 21 SHEET 1 C 5 LYS A 265 LEU A 268 0 SHEET 2 C 5 PHE A 257 THR A 260 -1 N PHE A 259 O TYR A 266 SHEET 3 C 5 GLN A 194 VAL A 201 -1 N HIS A 200 O GLU A 258 SHEET 4 C 5 ILE A 204 VAL A 213 -1 O CYS A 211 N ILE A 195 SHEET 5 C 5 THR A 298 LEU A 301 1 O PHE A 299 N ASN A 210 SHEET 1 D 2 ILE A 220 VAL A 222 0 SHEET 2 D 2 ILE A 289 GLY A 291 1 O ILE A 290 N ILE A 220 SHEET 1 E 4 ILE A 237 LYS A 238 0 SHEET 2 E 4 TYR A 245 LEU A 248 -1 O VAL A 246 N ILE A 237 SHEET 3 E 4 LEU A 284 LEU A 287 -1 O LEU A 287 N TYR A 245 SHEET 4 E 4 LEU A 274 HIS A 276 -1 N GLN A 275 O MET A 286 SHEET 1 F 6 ASP B 4 LEU B 8 0 SHEET 2 F 6 GLY B 166 ILE B 170 -1 O ILE B 170 N ASP B 4 SHEET 3 F 6 LEU B 153 TYR B 157 -1 N THR B 155 O THR B 169 SHEET 4 F 6 TYR B 309 ASP B 314 -1 O PHE B 313 N PHE B 154 SHEET 5 F 6 SER B 319 ALA B 325 -1 O GLY B 321 N VAL B 312 SHEET 6 F 6 TYR B 178 LYS B 186 -1 N GLU B 185 O VAL B 320 SHEET 1 G 8 GLU B 67 ASN B 76 0 SHEET 2 G 8 THR B 81 VAL B 93 -1 O VAL B 82 N MET B 75 SHEET 3 G 8 LEU B 96 ASP B 107 -1 O GLU B 104 N PHE B 85 SHEET 4 G 8 LEU B 40 PRO B 43 1 N VAL B 42 O VAL B 105 SHEET 5 G 8 GLY B 122 GLY B 125 -1 O ILE B 123 N TRP B 41 SHEET 6 G 8 GLN B 27 ASP B 34 1 N ILE B 32 O LEU B 124 SHEET 7 G 8 GLY B 18 VAL B 22 -1 N GLY B 18 O PHE B 31 SHEET 8 G 8 THR B 81 VAL B 93 -1 O THR B 92 N GLU B 21 SHEET 1 H 5 LYS B 265 LEU B 268 0 SHEET 2 H 5 PHE B 257 THR B 260 -1 N PHE B 259 O TYR B 266 SHEET 3 H 5 GLN B 194 VAL B 201 -1 N HIS B 200 O GLU B 258 SHEET 4 H 5 ILE B 204 VAL B 213 -1 O CYS B 211 N ILE B 195 SHEET 5 H 5 THR B 298 LEU B 301 1 O PHE B 299 N ASN B 210 SHEET 1 I 2 ILE B 220 VAL B 222 0 SHEET 2 I 2 ILE B 289 GLY B 291 1 O ILE B 290 N ILE B 220 SHEET 1 J 3 VAL B 246 LEU B 248 0 SHEET 2 J 3 LEU B 284 LEU B 287 -1 O CYS B 285 N THR B 247 SHEET 3 J 3 LEU B 274 HIS B 276 -1 N GLN B 275 O MET B 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.03 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.04 SSBOND 3 CYS B 47 CYS B 52 1555 1555 2.03 SSBOND 4 CYS B 249 CYS B 285 1555 1555 2.04 LINK C SER C 904 N DCL C 905 1555 1555 1.34 LINK C DCL C 905 N LEU C 906 1555 1555 1.45 LINK C SER D 904 N DCL D 905 1555 1555 1.33 LINK C DCL D 905 N LEU D 906 1555 1555 1.45 CISPEP 1 GLU A 112 PRO A 113 0 0.05 CISPEP 2 GLU B 112 PRO B 113 0 -0.02 SITE 1 AC1 22 ILE A 32 ASP A 34 GLY A 36 SER A 37 SITE 2 AC1 22 ALA A 38 MET A 75 ASN A 76 TYR A 77 SITE 3 AC1 22 VAL A 78 SER A 79 THR A 114 ILE A 123 SITE 4 AC1 22 LEU A 131 TYR A 192 GLY A 216 THR A 217 SITE 5 AC1 22 SER A 218 ILE A 290 PHE A 294 HOH A 350 SITE 6 AC1 22 HIS B 189 PRO B 295 SITE 1 AC2 23 HIS A 189 PRO A 295 ILE B 32 ASP B 34 SITE 2 AC2 23 GLY B 36 SER B 37 ALA B 38 MET B 75 SITE 3 AC2 23 ASN B 76 TYR B 77 VAL B 78 SER B 79 SITE 4 AC2 23 PHE B 111 THR B 114 ILE B 123 LEU B 131 SITE 5 AC2 23 TYR B 192 GLY B 216 THR B 217 SER B 218 SITE 6 AC2 23 ILE B 290 PHE B 294 HOH D 909 CRYST1 219.489 69.032 53.578 90.00 102.85 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004556 0.000000 0.001039 0.00000 SCALE2 0.000000 0.014486 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019144 0.00000